Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice

Immunopharmacology

Volumn 47, Issue 1, 2000, Pages 45-52

  Burger, Roger A ^a   Billingsley, Jonna L ^a   Huffman, John H ^b   Bailey, Kevin W ^b   Kim, Choung U ^c   Sidwell, Robert W ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b Institute for Antiviral Research   (United States)

^c Gilead Science   (United States)

Author keywords

Antiviral; Cytotoxic T cell; GS4104; Influenza; Macrophage; Natural killer cell; Neuraminidase inhibitor; Oseltamivir

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ANTIVIRUS AGENT; NEUTRALIZING ANTIBODY; OSELTAMIVIR; PLACEBO; PRODRUG; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMORAL IMMUNITY; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; LUNG; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; TARGET CELL; VIRUS TITRATION;

ACETAMIDES; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, SURFACE; ANTIVIRAL AGENTS; CYTOTOXICITY, IMMUNOLOGIC; ENZYME INHIBITORS; FEMALE; IMMUNE SYSTEM; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MACROPHAGES; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; SPLEEN; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033995157     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00184-8     Document Type: Article

References (21)

1. Bot A., Reichlin A., Isobe H., Bot S., Schulman J., Yokoyama W.M., Bona C.A. Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J. Virol. 70:1996;5668-5672.
2. Burger R.A., Warren R.P., Huffman J.H., Sidwell R.W. Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus. Immunopharmacol. Immunotoxicol. 17:1995;323-334.
3. Eisenberg E.J., Bidgood A., Cundy K.C. Penetration of GS4071, a novel neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug oseltamivir. Antimicrob. Agents Chemother. 41:1997;1949-1952.
4. Hayden F.G., Treanor J.J., Betts R.F., Lobo M., Esinhart J.D., Hussey E.K. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275:1996;295-299.
5. Hayden F.G., Atmar R.L., Schilling M., Johnson C., Poretz D., Paar D., Huson L., Ward P., Mills R.G. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N. Engl. J. Med. 341:1999;1336-1343.
6. Hayden F.G., Treanor J.J., Fritz R.S., Lobo M., Betts R.F., Miller M., Kinnersley N., Mills R.G., Ward P., Straus S.E. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. J. Am. Med. Assoc. 282:1999;1240-1246.
7. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., Stevens Interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119:1997;681-690.
8. Klenk H.-D., Rott R. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34:1998;247-280.
9. Li W.-X., Escarpe P.A., Eisenberg E.J., Cundy K.C., Sweet C., Jackeman K.J., Menson J., Lew W., Williams M., Zhang L., Kim C.U., Bischofberger N., Chen M.S., Mendel D.B. Identification of oseltamivir as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS4071. Antimicrob. Agents Chemother. 42:1998;647-653.
10. Liu C., Eichelberger M.C., Compans R.W., Air G.M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1995;1099-1106.
11. Mendel D., Tai C.Y., Escarpe P.A., Li W., Sidwell R.W., Huffman J.H., Sweet C., Jakeman K.J., Merson J., Lacy S.A., Lew W., Williams M.A., Zhang L., Chen M.S., Bischofberger N., Kim C.U. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother. 42:1998;640-646.
12. Mitchell D.M., McMichael A.J., Lamb J.R. The immunology of influenza. Br. Med. Bull. 41:1985;80-85.
13. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35:1979;69-75.
14. Ryan D.M., Ticehurst J., Dempsey M.H., Penn C.R. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:1994;2270-2275.
15. Sidwell R.W., Huffman J.H., Barnard D.L., Bailey K.W., Wong M.-H., Morrison A., Syndergaard T., Kim C.U. Inhibition of influenza virus infection in mice by oseltamivir, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res. 37:1998;107-120.
16. Sidwell R.W., Huffman J.H., Call E.W., Alaghamandan H., Cook P.D., Robins R.K. Effect of selenazofurin on influenza A and B virus infections in mice. Antiviral Res. 6:1985;343-353.
17. Sidwell R.W., Huffman J.H., Gilbert J., Moscon B., Pedersen G., Burger R.A., Warren R.P. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob. Agents Chemother. 36:1992;473-476.
18. Sidwell R.W., Smee D.F., Huffman J.H., Bailey K.W., Warren R.P., Burger R.A., Penney C.L. Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. Antiviral Res. 26:1995;145-159.
19. Smee D.F., Pease A., Burger R.A., Warren R.P., Bailey K.W., Sidwell R.W. An immunosuppressed mouse model of lethal murine gammaherpesvirus-68 infection for studying potential treatments of Epstein-Barr virus infections in man. Antiviral Chem. Chemother. 8:1998;573-581.
20. Von Itzstein M., Wu W.-Y., Kok G.B., Pegg M.S., Dayson J.C., Phan T.V., Smythe M.L., White H.F., Oliver S.W., Colman P.M., Vanghese J.N., Ryan D.M., Woods J.M., Bethell R.C., Hotham V.J., Cameron J.M., Penn C.R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 363:1993;418-423.
21. Woods J.M., Bethell R.C., Coates J.A.V., Healy N., Hiscox S.A., Pearson B.A., Ryan D.M., Ticehurst J., Tilling J., Walcott S.A., Penn C.R. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1993;1473-1479.